Sunvepra (asunaprevir)

pCPA File Number: 20911

Negotiation Status:

Concluded with an LOI

Indication(s):

Chronic Hepatitis C

Sponsor/Manufacturer:

Bristol Myers Squibb Canada Inc.

CDA-AMC Project Number:

SR0418-000

pCPA Engagement Letter Issued:

2016-07-20

Negotiation Process Concluded:

2017-02-17